The Enterprise Value as of December 2024 (TTM) for MAIA Biotechnology, Inc. (MAIA) is 41.72M

According to MAIA Biotechnology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 41.72M. This represents a change of -2.61% compared to the average of 42.84M of the last 4 quarters.

MAIA Biotechnology, Inc. (MAIA) Historical Enterprise Value (quarterly & annually)

How has MAIA Enterprise Value performed in the past?

The mean historical Enterprise Value of MAIA Biotechnology, Inc. over the last ten years is 31.97M. The current 41.72M Enterprise Value has changed 12.95% with respect to the historical average. Over the past ten years (40 quarters), MAIA's Enterprise Value was at its highest in in the June 2024 quarter at 64.80M. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.

MAIA Biotechnology, Inc. (MAIA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of MAIA Biotechnology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MAIA Biotechnology, Inc. (MAIA) Average Enterprise Value

How has MAIA Enterprise Value performed in the past?

The current Enterprise Value of MAIA Biotechnology, Inc. (MAIA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

MAIA Biotechnology, Inc. (MAIA) Enterprise Value vs. Peers

How is MAIA’s Enterprise Value compared to its peers?

MAIA Biotechnology, Inc.’s Enterprise Value is less than Lineage Cell Therapeutics, Inc. (93.41M), less than Armata Pharmaceuticals, Inc. (197.00M), less than Frequency Therapeutics, Inc. (384.22M), greater than Portage Biotech Inc. (4.08M), greater than AgeX Therapeutics, Inc. (19.70M), less than Larimar Therapeutics, Inc. (211.48M), greater than Graphite Bio, Inc. (-15007658.00), greater than Lyra Therapeutics, Inc. (22.80M), less than Genelux Corporation (78.48M), greater than Comera Life Sciences Holdings, Inc. (-1590126.00), less than Dyadic International, Inc. (50.93M), greater than Cingulate Inc. (5.81M), less than Monopar Therapeutics Inc. (110.36M), less than Transgene SA (76.48M), less than Eupraxia Pharmaceuticals Inc. (151.38M), less than Champions Oncology, Inc. (112.78M), greater than Lumos Pharma, Inc. (24.19M), less than Roivant Sciences Ltd. (6.82B), greater than Field Trip Health & Wellness Ltd. (-7193195.00), less than Telix Pharmaceuticals Limited (8.28B), less than Nautilus Biotechnology, Inc. (244.38M),

Build a custom stock screener for MAIA Biotechnology, Inc. (MAIA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MAIA Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MAIA Biotechnology, Inc. (MAIA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MAIA Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.